[HTML][HTML] Regulatory T cells in autoimmune hepatitis: unveiling their roles in mouse models and patients
H Wang, X Feng, W Yan, D Tian - Frontiers in Immunology, 2020 - frontiersin.org
Autoimmune hepatitis (AIH) is a severe and chronic liver disease, and its incidence has
increased worldwide in recent years. Research into the pathogenesis of AIH remains limited …
increased worldwide in recent years. Research into the pathogenesis of AIH remains limited …
Autoimmune hepatitis: progress from global immunosuppression to personalised regulatory T cell therapy
NN Than, HC Jeffery, YH Oo - Canadian Journal of …, 2016 - Wiley Online Library
Autoimmune hepatitis (AIH) is an immune mediated liver injury. The precise aetiology of AIH
is still unknown but current evidence suggests both genetic and environmental factors are …
is still unknown but current evidence suggests both genetic and environmental factors are …
[HTML][HTML] The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis
G Wang, A Tanaka, H Zhao, J Jia, X Ma… - Hepatology …, 2021 - Springer
Guiqiang Wang1, 18· Atsushi Tanaka2· Hong Zhao1, 1 8· Jidong Jia3· Xiong Ma4· Kenichi
Harada5· Fu‑Sheng Wang6· Lai Wei7· Qixia Wang4· Ying Sun6· Yuan Hong1· Huiying …
Harada5· Fu‑Sheng Wang6· Lai Wei7· Qixia Wang4· Ying Sun6· Yuan Hong1· Huiying …
[HTML][HTML] Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
NN Than, J Hodson, D Schmidt-Martin, R Taubert… - JHEP Reports, 2019 - Elsevier
Background & Aims Treatment options remain limited for patients with autoimmune hepatitis
(AIH), while there are still concerns over the consequences of long-term corticosteroid use. A …
(AIH), while there are still concerns over the consequences of long-term corticosteroid use. A …
Support of precision medicine through risk-stratification in autoimmune liver diseases–histology, scoring systems, and non-invasive markers
L Bossen, A Gerussi, V Lygoura, GF Mells… - Autoimmunity …, 2018 - Elsevier
Autoimmune liver diseases (AILDs) are complex conditions, which arise from the interaction
between a genetic susceptibility and unknown environmental triggers. They represent a …
between a genetic susceptibility and unknown environmental triggers. They represent a …
[HTML][HTML] Levels of serum IgG subclasses in patients with liver disease: A retrospective study
W Zheng, F Jiang, J Shan, Y Wang… - Experimental and …, 2021 - spandidos-publications.com
Viral and alcoholic liver disease, drug induced liver disease (DILD), primary biliary cirrhosis
(PBC) and autoimmune hepatitis (AIH) are among the most common liver diseases …
(PBC) and autoimmune hepatitis (AIH) are among the most common liver diseases …
Long-term outcome of Autoimmune Hepatitis: consecutive patient cohort and data on the second twenty years
L Harrison, B Hoeroldt, H Dhaliwal, E Wadland… - Digestive and Liver …, 2023 - Elsevier
Background Mortality rates for autoimmune hepatitis (AIH) vary. Data are lacking beyond 20
years follow-up. Aims Analysis of a consecutively recruited large AIH cohort from a single …
years follow-up. Aims Analysis of a consecutively recruited large AIH cohort from a single …
Autoimmune Hepatitis in the East and the West
Autoimmune hepatitis (AIH) is a chronic progressive liver disease characterized by
unresolving inflammation of the liver, hypergammaglobulinemia, production of …
unresolving inflammation of the liver, hypergammaglobulinemia, production of …
2010-2017 tarihleri arasında otoimmün hepatit tanılı erişkin hastaların retrospektif olarak epidemiyolojik değerlendirilmesi
AC Ertem - 2018 - search.proquest.com
Otoimmün hepatit (OİH), etiyolojisi bilinmeyen immün sistem aracılı karaciğer hastalığıdır.
Dolaşımda otoantikorların varlığı ve yüksek serum globulin konsantrasyonlarının olduğu …
Dolaşımda otoantikorların varlığı ve yüksek serum globulin konsantrasyonlarının olduğu …